Paper14607828
Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.
Lai Y and 2 others. J Biol Chem, 2004. Cited by 112 papers, by iCite.
Cite this record
ConductScience Library. Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs. Papers, record 14607828. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/14607828
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mitochondrial expression of the human equilibrative nucleoside transporter 1 (hENT1) results in enhanced mitochondrial toxicity of antiviral drugs.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Arabinofuranosyluracil | Major topic |
| Equilibrative Nucleoside Transporter 1 | Major topic |
| Mitochondria, Liver | Major topic |
| Animals | |
| Biological Transport, Active | |
| Cell Line | |
| Dogs | |
| Humans | |
| In Vitro Techniques | |
| Intracellular Membranes | |
| Membrane Transport Proteins | |
| Recombinant Fusion Proteins | |
| Subcellular Fractions |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GM54447 | NIGMS NIH HHS | United States | R01GM054447 | PubMed and NIH |
Source NIH RePORTER
Cited by45
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41652173 | SLC6A6 imports taurine into mitochondria to sustain mitochondrial translation and tumour growth. | Nat Metab | 2026 | https://conductscience.org/library/papers/41652173 | PubMed |
| 40958018 | Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes. | Arch Toxicol | 2025 | https://conductscience.org/library/papers/40958018 | PubMed |
| 40900667 | ToxPoint: The case for Equilibrative Nucleoside Transporters in current regulatory guidance. | Toxicol Sci | 2025 | https://conductscience.org/library/papers/40900667 | PubMed |
| 40824221 | High tide or low tide: the transport and metabolism of mitochondrial nucleotides. | Biochem J | 2025 | https://conductscience.org/library/papers/40824221 | PubMed |
| 40083698 | Mitochondrial Localization and Function of Adenosine Receptors. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40083698 | PubMed |
| 39983672 | Solute carriers: The gatekeepers of metabolism. | Cell | 2025 | https://conductscience.org/library/papers/39983672 | PubMed |
| 38223529 | A mechanistic biomarker investigation of fialuridine hepatotoxicity using the chimeric TK-NOG Hu-liver mouse model and in vitro micropatterned hepatocyte cocultures. | Toxicol Res (Camb) | 2024 | https://conductscience.org/library/papers/38223529 | PubMed |
| 37404197 | Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development. | Clin Pharmacol Ther | 2023 | https://conductscience.org/library/papers/37404197 | PubMed |
| 36864321 | Modeling drug-induced liver injury and screening for anti-hepatofibrotic compounds using human PSC-derived organoids. | Cell Regen | 2023 | https://conductscience.org/library/papers/36864321 | PubMed |
| 36052127 | Preclinical Pharmacokinetics and In Vitro Properties of GS-441524, a Potential Oral Drug Candidate for COVID-19 Treatment. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/36052127 | PubMed |
| 35656081 | Antiproliferative and apoptotic activity of gemcitabine-lauric acid conjugate on human bladder cancer cells. | Iran J Basic Med Sci | 2022 | https://conductscience.org/library/papers/35656081 | PubMed |
| 35257288 | Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery. | Pharm Res | 2022 | https://conductscience.org/library/papers/35257288 | PubMed |
| 35047893 | Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury. | Front Med Technol | 2020 | https://conductscience.org/library/papers/35047893 | PubMed |
| 34635103 | Emerging roles of dysregulated adenosine homeostasis in brain disorders with a specific focus on neurodegenerative diseases. | J Biomed Sci | 2021 | https://conductscience.org/library/papers/34635103 | PubMed |
| 34208592 | Therapy Prospects for Mitochondrial DNA Maintenance Disorders. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34208592 | PubMed |
| 33690842 | The equilibrative nucleoside transporter ENT1 is critical for nucleotide homeostasis and optimal erythropoiesis. | Blood | 2021 | https://conductscience.org/library/papers/33690842 | PubMed |
| 32730777 | The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine. | Toxicol Appl Pharmacol | 2020 | https://conductscience.org/library/papers/32730777 | PubMed |
| 31748707 | Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models. | Nat Rev Drug Discov | 2020 | https://conductscience.org/library/papers/31748707 | PubMed |
| 31600844 | Identification of a novel heterozygous guanosine monophosphate reductase (GMPR) variant in a patient with a late-onset disorder of mitochondrial DNA maintenance. | Clin Genet | 2020 | https://conductscience.org/library/papers/31600844 | PubMed |
| 30059145 | Advancing Predictions of Tissue and Intracellular Drug Concentrations Using In Vitro, Imaging and Physiologically Based Pharmacokinetic Modeling Approaches. | Clin Pharmacol Ther | 2018 | https://conductscience.org/library/papers/30059145 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| SLC28A1 | 9154 | PubTator's text mining | https://conductscience.org/library/genes/9154 | NCBI Gene |
| SLC29A1 | 2030 | PubTator's text mining | https://conductscience.org/library/genes/2030 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/14607828
GET https://conductscience.org/api/papers/v1/14607828/cited_by?page=2